NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease.
Juan Martínez-MillaÁlvaro AceñaAna PelloMarta López-CastilloHans Paul GaebeltÓscar González-LorenzoNieves TarínCarmen CristóbalLuis Miguel Blanco ColioJosé Luis Martín-VenturaAna HuelmosAndrea KallmeyerJoaquín AlonsoCarlos Gutiérrez-LandaluceLorenzo López BescósJesús EgidoIgnacio Mahillo FernándezÓscar LorenzoMaría Luisa González-CasausJosé Tuñón FernándezPublished in: Journal of clinical medicine (2022)
In patients with SCAD and NT-ProBNP > 125 pg/mL, PTH and NT-ProBNP, which are markers related to ventricular damage, are predictors of poor outcome. In the subgroup of patients with NT-ProBNP ≤ 125 pgm/L, calcidiol and non-HDL cholesterol, which are more related to vascular damage, are the independent predictors of poor outcome. Then, in patients with SCAD, baseline NT-ProBNP may influence the type of biomarker that is effective in risk prediction.